Defined conjugation of glycans to the lysines of CRM197 guided by their reactivity mapping (Q35116917)

6 August 2017

title

Defined conjugation of glycans to the lysines of CRM197 guided by their reactivity mapping (English)

1 reference

6 August 2017

6

Werner Pansegrau

1 reference

6 August 2017

8

Francesco Berti

1 reference

6 August 2017

Stefano Crotti

1

1 reference

6 August 2017

Huili Zhai

2

1 reference

6 August 2017

Jing Zhou

3

1 reference

6 August 2017

Martin Allan

4

1 reference

6 August 2017

Daniela Proietti

5

1 reference

6 August 2017

Qi-Ying Hu

7

1 reference

6 August 2017

Roberto Adamo

9

1 reference

6 August 2017

publication date

11 March 2014

1 reference

6 August 2017

1 reference

6 August 2017

volume

15

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

836-843

1 reference

The design of semi-synthetic and synthetic glycoconjugate vaccines

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Synthetically defined glycoprotein vaccines: current status and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM(197) conjugates induce protection against Streptococcus pneumoniae type 3 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Recent mechanistic insights on glycoconjugate vaccines and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Recent developments in synthetic oligosaccharide-based bacterial vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Nonnatural amino acids for site-specific protein conjugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Site-selective glycosylation of proteins: creating synthetic glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Facile conversion of cysteine and alkyl cysteines to dehydroalanine on protein surfaces: versatile and switchable access to functionalized proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Preparation of glycoconjugates by dialkyl squarate chemistry revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Glycation sites in neoglycoglycoconjugates from the terminal monosaccharide antigen of the O‐PS of Vibrio cholerae O1, serotype Ogawa, and BSA revealed by matrix‐assisted laser desorption–ionization tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Determination of the glycation sites of Bacillus anthracis neoglycoconjugate vaccine by MALDI-TOF/TOF-CID-MS/MS and LC-ESI-QqTOF-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Mapping the glycation sites in the neoglycoconjugate from hexasaccharide antigen of Vibrio cholerae, serotype Ogawa and the recombinant tetanus toxin C-fragment carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Analysis and optimization of copper-catalyzed azide-alkyne cycloaddition for bioconjugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Enhanced immunogenicity of a tricomponent mannan tetanus toxoid conjugate vaccine targeted to dendritic cells via Dectin-1 by incorporating β-glucan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Tobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Saturation transfer difference 1D-TOCSY experiments to map the topography of oligosaccharides recognized by a monoclonal antibody directed against the cell-wall polysaccharide of group A streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

The capsular polysaccharide of Enterococcus faecalis and its relationship to other polysaccharides in the cell wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Novel oligosaccharide side chains of the collagen-like region of BclA, the major glycoprotein of the Bacillus anthracis exosporium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Transglutaminase-mediated PEGylation of proteins: direct identification of the sites of protein modification by mass spectrometry using a novel monodisperse PEG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Mapping protein post-translational modifications with mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Stable isotope-free relative and absolute quantitation of protein phosphorylation stoichiometry by MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

On studying protein phosphorylation patterns using bottom-up LC-MS/MS: the case of human alpha-casein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Evaluation of comparative protein modeling by MODELLER

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

pH-selective mutagenesis of protein-protein interfaces: in silico design of therapeutic antibodies with prolonged half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

Solution stability studies of the subunit components of meningococcal C oligosaccharide-CRM197 conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

The use of circular dichroism in the investigation of protein structure and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

A Potentially Valuable Advance in the Synthesis of Carbohydrate-Based Anticancer Vaccines through Extended Cycloaddition Chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201300785

21 January 2018

Identifiers

DOI

10.1002/CBIC.201300785

1 reference

6 August 2017

1 reference